Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride – statnews.com

Posted on by
  1. Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride  statnews.com
  2. Lilly to buy Boston biotech Kelonia for $3.25 billion in latest Mass. investment  The Boston Globe
  3. Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion  CNBC
  4. Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company  investor.lilly.com
  5. Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says  Yahoo
Share
XLinkedInWhatsAppTelegramPinterestReddit

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *